Health and Happiness (H&H) International Holdings Limited

8BI · F · Consumer Defensive / Packaged Foods

2.86EUR-0.10 (-3.38%)

Price History

Full chart

Market Stats

Previous Close2.96

Open2.86

Day Range2.86 – 2.86

52-Week Range1.05 – 2.20

Volume0

Market Cap1.42B

P/E (TTM)14.67

Forward P/E18.21

EPS0.15

Dividend Yield5.07%

Beta1.38

50-Day Avg1.81

200-Day Avg1.51

About

Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition and care, and pet nutrition and care products in Mainland China, Australia, New Zealand, North America, and internationally. The company offers milk formulas for infants, children, and expectant and nursing mothers; probiotic and nutrition supplements in the form of sachets, capsules, gummies, and tablets for infants, children, and expectant mothers; and vitamins, herbal and mineral supplements, and skin care and sports nutrition products for adults; dried baby food and baby care products; and complete pet food products and multicondition pet supplements. In addition, it is involved in the research, development, manufacture, sale, and processing of meat, fruit, vegetable powder, candy, special nutritional food, and nutritional products; marketing and distribution of organic baby food; wholesale, retail, import, and export of nutritional food and personal care products for infants; and provision of packaging services. Further, the company engages in the trading and sale of vitamins, health supplements, and skin care and sports nutrition products for adults; and pet food, and nutritional supplements for pets, as well as the online sale and provision of software and information technology. It provides its products under the Healthy Times, Farmland, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, and Good Goût brand names. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Coliving Holdings Limited.

Company Details

SectorConsumer Defensive
IndustryPackaged Foods
CEOMr. Akash Bedi
Employees2.76K
HeadquartersOne Island East, Quarry Bay, Hong Kong, Germany
Websitehttps://www.hh.global

Leadership

Mr. Fei LuoExecutive Chairman of the Board · b. 1964
Mr. Yidong WangCFO & Executive Director · b. 1974
Mr. Akash BediCEO & CEO of Europe, North America, Middle East and India · b. 1985
Dr. Johannes Jacobus CapponChief Technology Officer · b. 1966
Ms. Pascale LabordeChief Growth & Sustainability Officer and Director of Global Marketing and Communications · b. 1980
Mr. Qizhang ZhangChief People Officer · b. 1984
Ms. Fengting LiChief Executive Officer for China · b. 1986
Mr. Nicholas Russell Lamande MannChief Executive Officer for Asia, Australia & New Zealand · b. 1975
Mr. Christian SimChief Supply Chain Officer · b. 1974
Ms. Wenyun YangSenior Director of the Listing Affairs & Risk Management Department and Company Secretary · b. 1984

Financials

Income Statement

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	4.56B	4.73B	4.82B	6.51B	8.10B	10.13B	10.93B	11.19B	11.55B	12.78B	13.93B	13.05B	14.35B
Growth (%)	-	+3.73%	+1.84%	+35.01%	+24.44%	+25.16%	+7.82%	+2.47%	+3.15%	+10.63%	+9.01%	-6.28%	+9.97%
Cost of Revenue	1.59B	1.80B	1.83B	2.45B	2.83B	3.39B	3.70B	4.01B	4.30B	5.07B	5.63B	5.14B	5.39B
Gross Profit	2.98B	2.93B	2.98B	4.06B	5.27B	6.74B	7.23B	7.19B	7.25B	7.70B	8.29B	7.92B	8.96B
Gross Margin	65.23%	61.86%	61.94%	62.39%	65.04%	66.52%	66.16%	64.20%	62.76%	60.30%	59.56%	60.65%	62.45%
Operating Expense	1.75B	1.84B	2.32B	2.30B	3.18B	4.29B	5.07B	5.23B	5.63B	5.93B	6.36B	6.52B	7.25B
Operating Income	1.23B	1.08B	666.30M	1.76B	2.09B	2.45B	2.16B	1.95B	1.62B	1.77B	1.94B	1.40B	1.71B
Operating Margin	26.95%	22.92%	13.83%	27.06%	25.78%	24.19%	19.76%	17.46%	13.99%	13.87%	13.91%	10.73%	11.91%
EBITDA	-	-	-	-	2.07B	2.12B	2.19B	2.13B	1.42B	1.87B	2.04B	1.37B	1.56B
EBITDA Margin	-	-	-	-	25.58%	20.91%	20.01%	19.05%	12.29%	14.66%	14.67%	10.48%	10.87%
Net Income	820.72M	806.79M	250.69M	954.40M	932.85M	843.15M	1.01B	1.14B	508.48M	611.78M	581.85M	-53.72M	196.14M
Net Income Margin	17.99%	17.05%	5.20%	14.67%	11.52%	8.32%	9.20%	10.15%	4.40%	4.79%	4.18%	-0.41%	1.37%
R&D	-	-	-	-	-	-	-	-	-	-	-	242.98M	216.20M
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	-	-	1.86%	1.51%
Interest Expense	0	0	0	0	0	415.40M	364.55M	244.02M	263.74M	530.29M	807.61M	869.87M	685.55M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	4.10%	3.34%	2.18%	2.28%	4.15%	5.80%	6.66%	4.78%

Balance Sheet

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	4.64B	6.63B	13.84B	14.21B	14.13B	14.85B	15.86B	17.22B	20.28B	20.96B	20.04B	18.84B	19.40B
Total Liabilities	2.13B	3.71B	10.24B	11.01B	9.92B	10.01B	10.27B	11.02B	14.40B	14.82B	13.75B	13.03B	13.41B
Total Equity	2.52B	2.92B	3.29B	3.16B	4.21B	4.85B	5.59B	6.20B	5.89B	6.14B	6.30B	5.81B	5.99B
Cash	1.66B	3.35B	1.20B	1.51B	2.09B	1.91B	2.22B	1.83B	2.40B	2.30B	1.36B	1.60B	1.67B
Net Debt	-	-	-	-	4.19B	4.05B	3.66B	4.19B	6.98B	7.26B	7.75B	7.68B	7.23B

Cash Flow

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	660.47M	972.17M	365.73M	1.54B	1.95B	1.70B	1.44B	1.53B	1.89B	1.47B	1.10B	1.35B	1.54B
Investing Cash Flow	-80.75M	-460.39M	-4.16B	-735.50M	-264.19M	-748.60M	-277.19M	-1.24B	-4.01B	-	-	-	-
Financing Cash Flow	-214.67M	1.17B	2.57B	-657.51M	-848.61M	-1.12B	-869.12M	-687.68M	2.77B	-1.49B	-	-	-
Capital Expenditure	135.70M	134.60M	109.04M	88.39M	73.56M	63.19M	104.97M	81.33M	53.27M	102.49M	90.97M	97.31M	94.36M
Free Cash Flow	-	-	-	-	1.37B	1.43B	1.31B	1.43B	1.78B	1.37B	1.01B	1.25B	1.44B
Dividends Paid	308.33M	334.82M	196.05M	-	271.52M	271.52M	271.52M	862.11M	407.52M	233.62M	474.53M	281.91M	141.46M
FCF to OCF	-	-	-	-	70.06%	84.54%	90.78%	93.05%	94.36%	93.02%	91.71%	92.77%	93.86%
Dividend Paid to FCF	-	-	-	-	19.87%	18.92%	20.78%	60.45%	22.85%	17.09%	47.18%	22.57%	9.81%

Earnings

Report Date	Mar 23, 2027
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	After-hours

Key Statistics & Ratios

Market Cap1.42B

Enterprise Value2.04B

Trailing P/E14.67

Forward P/E18.21

PEG Ratio0.00

Price / Sales0.09

Price / Book1.49

EPS0.15

Book Value1.30

Revenue (TTM)16.03B

Gross Profit (TTM)10.26B

EBITDA2.49B

Profit Margin4.59%

Operating Margin17.92%

Return on Equity11.75%

Return on Assets7.33%

Shares Outstanding645.56M

Shares Float208.90M

Beta1.38

Dividend Yield5.07%

Dividend Rate0.11

Payout Ratio27.13%

Dividends

20262×

0.09Sep 10, 20260.02May 19, 2026

20252×

0.02Sep 9, 20250.01May 15, 2025

20242×

0.03Sep 10, 20240.02May 14, 2024

20232×

0.05Sep 4, 20230.04May 16, 2023

20222×

0.03Sep 9, 20220.02May 17, 2022

20212×

0.04Sep 7, 20210.04May 17, 2021

20202×

0.07Sep 8, 20200.09May 12, 2020

20191×

0.05May 15, 2019

20151×

0.05May 20, 2015

20142×

0.03Sep 2, 20140.09May 12, 2014

20132×

0.05Sep 2, 20130.09May 13, 2013

20122×

0.03Aug 30, 20120.07May 3, 2012

20112×

0.02Sep 5, 20110.02Jun 2, 2011